FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jerome Ritz

Research Profile

Procedures

Chemicals & Drugs

Anatomy

Disorders

Physiology

Co-author Network

Publications

TOP 3
Sarah Nikiforow; Jerome Ritz; Robert J Soiffer; Edwin P Alyea; Joseph H Antin; Philippe Armand; Bhavjot Bindra; Bruce R Blazar; Brett Glotzbecker; Vincent T Ho; Haesook T Kim; John Koreth; Sean McDonough; Corey Cutler
Phase I Study of Alemtuzumab for Therapy of Steroid-Refractory Chronic Graft-versus-Host Disease.
Ken-ichi Matsuoka; Sean McDonough; Kazuyuki Murase; Robert J Soiffer; Edwin P Alyea; Joseph H Antin; Philippe Armand; Gregory Bascug; Bruce R Blazar; Corey Cutler; Vincent T Ho; Yutaka Kawano; Haesook T Kim; John Koreth; Jerome Ritz
Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease.
Y-B Chen; Bimalangshu R Dey; C Illiano; Madan H Jagasia; J Kennedy; Steven McAfee; S McDonough; Eyal C Attar; Karen K Ballen; H Chen; Robert J Soiffer; Thomas R Spitzer; Jerome Ritz
Expression of α4β7 integrin on memory CD8(+) T cells at the presentation of acute intestinal GVHD.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jerome Ritz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sarah Nikiforow; Jerome Ritz; Robert J Soiffer; Edwin P Alyea; Joseph H Antin; Philippe Armand; Bhavjot Bindra; Bruce R Blazar; Brett Glotzbecker; Vincent T Ho; Haesook T Kim; John Koreth; Sean McDonough; Corey Cutler
Phase I Study of Alemtuzumab for Therapy of Steroid-Refractory Chronic Graft-versus-Host Disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(5):804-11.
2013: Ken-ichi Matsuoka; Sean McDonough; Kazuyuki Murase; Robert J Soiffer; Edwin P Alyea; Joseph H Antin; Philippe Armand; Gregory Bascug; Bruce R Blazar; Corey Cutler; Vincent T Ho; Yutaka Kawano; Haesook T Kim; John Koreth; Jerome Ritz
Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease.
Science translational medicine 2013;5(179):179ra43.
2013: Y-B Chen; Bimalangshu R Dey; C Illiano; Madan H Jagasia; J Kennedy; Steven McAfee; S McDonough; Eyal C Attar; Karen K Ballen; H Chen; Robert J Soiffer; Thomas R Spitzer; Jerome Ritz
Expression of α4β7 integrin on memory CD8(+) T cells at the presentation of acute intestinal GVHD.
Bone marrow transplantation 2013;48(4):598-603.
2013: B Glotzbecker; Vincent T Ho; G Horowitz; Haesook T Kim; Jerome Ritz; J Aldridge; David Avigan; Robert J Soiffer; Jacalyn Rosenblatt
Low levels of 25-hydroxyvitamin D before allogeneic hematopoietic SCT correlate with the development of chronic GVHD.
Bone marrow transplantation 2013;48(4):593-7.
2013: Lee Gazourian; Vincent T Ho; Jerome Ritz; Angela J Rogers; Robert J Soiffer; Joseph H Antin; Rebecca M Baron; Anna Maria F Coronata; Gerald L Weinhouse; George R Washko
Airway dilation in bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.
Respiratory medicine 2013;107(2):276-83.
2012: John Koreth; Sean M McDonough; Jerome Ritz; Robert J Soiffer; Kristen E Stevenson; Joseph H Antin; Philippe Armand; Bhavjot Bindra; Bruce R Blazar; Corey Cutler; Vincent T Ho; Haesook T Kim; Edwin P Alyea
Bortezomib-based graft-versus-host disease prophylaxis in HLA-mismatched unrelated donor transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(26):3202-8.
2012: Philippe Armand; Corey Cutler; H Joachim Deeg; Christopher J Gibson; Vincent T Ho; John Koreth; Stephanie J Lee; Jerome Ritz; Robert J Soiffer; Mohamed L Sorror; Barry E Storer; Edwin P Alyea; Joseph H Antin; Frederick R Appelbaum; Haesook T Kim
A disease risk index for patients undergoing allogeneic stem cell transplantation.
Blood 2012;120(4):905-13.
2012: Yi-Bin Chen; Erin Coughlin; Corey S Cutler; Robert P Hasserjian; Christina Illiano; Madan H Jagasia; Sean McDonough; In Sun Park; Robert J Soiffer; Thomas R Spitzer; Heidi Chen; Jerome Ritz
Expression of CD30 in patients with acute graft-versus-host disease.
Blood 2012;120(3):691-6.
2012: Yi-Bin Chen; Corey Cutler; Julie Aldridge; Edwin P Alyea; Joseph H Antin; Philippe Armand; Karen K Ballen; Greg Bourdeau; Grace Kao; Haesook T Kim; John Koreth; Deborah Liney; Jerome Ritz; Robert J Soiffer; Thomas R Spitzer; Vincent T Ho
Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(5):805-12.
2012: Caron A Jacobson; Grace S Kao; Haesook T Kim; John Koreth; Sean M McDonough; Carol G Reynolds; Robert J Soiffer; Kristen E Stevenson; Amin T Turki; Edwin P Alyea; Joseph H Antin; Philippe Armand; Karen K Ballen; Yi-Bin Chen; Corey Cutler; Maria I Herrera; Vincent T Ho; Jerome Ritz
Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(4):565-74.
2012: Mathangi Srinivasan; Patricia A Taylor; Joseph H Antin; Jeffrey L Browning; Ryan Flynn; Leo Luznik; William Murphy; Angela Panoskaltsis-Mortari; Andrew Price; Ann Ranger; Jerome Ritz; Mark J Shlomchik; Bruce R Blazar
Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.
Blood 2012;119(6):1570-80.
2011: John Koreth; Ken-ichi Matsuoka; Sean M McDonough; Sashank Prasad; Jerome Ritz; Nathaniel S Treister; Dimitrios Tzachanis; Edwin P Alyea; Joseph H Antin; Philippe Armand; David Avigan; Don C Bienfang; Bhavjot Bindra; Corey Cutler; Vincent T Ho; Robin M Joyce; Haesook T Kim; Robert J Soiffer
Interleukin-2 and regulatory T cells in graft-versus-host disease.
The New England journal of medicine 2011;365(22):2055-66.
2011: Caron A Jacobson; Jerome Ritz
Time to put the CAR-T before the horse.
Blood 2011;118(18):4761-2.
2011: Yutaka Kawano; Haesook T Kim; John Koreth; Ken-Ichi Matsuoka; Sean McDonough; Edwin P Alyea; Joseph H Antin; Gregory Bascug; Corey Cutler; Vincent T Ho; Robert J Soiffer; Jerome Ritz
Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation.
Blood 2011;118(18):5021-30.
2011: Fabrice Porcheray; Jerome Ritz; Stefanie Sarantopoulos; Robert J Soiffer; Edwin P Alyea; Joseph H Antin; Roberto Bellucci; Blair H Floyd; David B Miklos; Emmanuel Zorn
Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.
Transplantation 2011;92(3):359-65.
2011: Vincent T Ho; Grace Kao; Haesook T Kim; John Koreth; Deborah Liney; Jerome Ritz; Robert J Soiffer; Julie Aldridge; Joseph H Antin; Philippe Armand; Corey Cutler; Edwin P Alyea
Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(8):1196-204.
2011: Corey Cutler; K Stevenson; Haesook T Kim; J Brown; S McDonough; M Herrera; C Reynolds; Deborah Liney; Grace S Kao; Vincent T Ho; Philippe Armand; John Koreth; Edwin P Alyea; Bimalangshu R Dey; Eyal C Attar; Thomas R Spitzer; Vassiliki A Boussiotis; Jerome Ritz; Robert J Soiffer; Joseph H Antin; Karen K Ballen
Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis.
Bone marrow transplantation 2011;46(5):659-67.
2011: Jing Ouyang; Przemyslaw Juszczynski; Scott J Rodig; Michael Green; Evan O'Donnell; Treeve Currie; Myriam Armant; Kunihiko Takeyama; Stefano Monti; Gabriel A Rabinovich; Jerome Ritz; Jeffery L Kutok; Margaret A Shipp
Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders.
Blood 2011;117(16):4315-22.
2011: Shuqiang Li; Howell F Moffett; Jun Lu; Lillian Werner; Hao Zhang; Jerome Ritz; Donna Neuberg; Kai W Wucherpfennig; Jennifer R Brown; Carl D Novina
MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cells.
PloS one 2011;6(3):e16956.
2011: Christopher G Turner; Justin D Klein; Shaun A Steigman; Myriam Armant; Grace A Nicksa; David Zurakowski; Jerome Ritz; Dario O Fauza
Preclinical regulatory validation of an engineered diaphragmatic tendon made with amniotic mesenchymal stem cells.
Journal of pediatric surgery 2011;46(1):57-61.
2011: Grace S Kao; Haesook T Kim; Heather Daley; Jerome Ritz; Scott R Burger; Linda Kelley; Cynthia Vierra-Green; Sue Flesch; Stephen Spellman; John Miller; Dennis Confer
Validation of short-term handling and storage conditions for marrow and peripheral blood stem cell products.
Transfusion 2011;51(1):137-47.
2010: Stacy E F Melanson; Kristen Stevenson; Haesook Kim; Joseph H Antin; Michael H Court; Vincent T Ho; Jerome Ritz; Robert J Soiffer; Frank C Kuo; Janina A Longtine; Petr Jarolim
Allelic variations in CYP2B6 and CYP2C19 and survival of patients receiving cyclophosphamide prior to myeloablative hematopoietic stem cell transplantation.
American journal of hematology 2010;85(12):967-71.
2010: Corey Cutler; Haesook T Kim; Shaké Ayanian; Gary Bradwin; Carolyn Revta; Julie Aldridge; Vincent T Ho; Edwin P Alyea; John Koreth; Philippe Armand; Robert J Soiffer; Jerome Ritz; Paul G Richardson; Joseph H Antin
Prediction of veno-occlusive disease using biomarkers of endothelial injury.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(8):1180-5.
2010: John Koreth; Julie Aldridge; Haesook T Kim; Edwin P Alyea; Corey Cutler; Philippe Armand; Jerome Ritz; Joseph H Antin; Robert J Soiffer; Vincent T Ho
Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(6):792-800.
2010: Ken-ichi Matsuoka; Haesook T Kim; Sean McDonough; Gregory Bascug; Ben Warshauer; John Koreth; Corey Cutler; Vincent T Ho; Edwin P Alyea; Joseph H Antin; Robert J Soiffer; Jerome Ritz
Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.
The Journal of clinical investigation 2010;120(5):1479-93.
2010: Ovidiu Marina; Ursula Hainz; Melinda A Biernacki; Wandi Zhang; Ann Cai; Jonathan S Duke-Cohan; Fenglong Liu; Vladimir Brusic; Donna Neuberg; Jeffery L Kutok; Edwin P Alyea; Christine M Canning; Robert J Soiffer; Jerome Ritz; Catherine J Wu
Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens.
Cancer research 2010;70(4):1344-55.
2010: Akinori Yoda; Yuka Yoda; Sabina Chiaretti; Michal Bar-Natan; Kartik Mani; Scott J Rodig; Nathan West; Yun Xiao; Jennifer R Brown; Constantine Mitsiades; Martin Sattler; Jeffery L Kutok; Daniel J DeAngelo; Martha Wadleigh; Alfonso Piciocchi; Paola Dal Cin; James E Bradner; James D Griffin; Kenneth C Anderson; Richard M Stone; Jerome Ritz; Robin Foà; Jon C Aster; David A Frank; David M Weinstock
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(1):252-7.
2009: Steven A McCarroll; James E Bradner; Hannu Turpeinen; Liisa Volin; Paul J Martin; Shannon D Chilewski; Joseph H Antin; Stephanie J Lee; Tapani Ruutu; Barry Storer; Edus H Warren; Bo Zhang; Lue Ping Zhao; David Ginsburg; Robert J Soiffer; Jukka Partanen; John A Hansen; Jerome Ritz; Aarno Palotie; David Altshuler
Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease.
Nature genetics 2009;41(12):1341-4.
2009: Niraj C Patel; Javier Chinen; Howard M Rosenblatt; I Celine Hanson; Robert A Krance; Mary E Paul; Stuart L Abramson; Lenora M Noroski; Carla M Davis; Filiz O Seeborg; Samuel B Foster; Kathryn S Leung; Betty S Brown; Jerome Ritz; William T Shearer
Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioning.
The Journal of allergy and clinical immunology 2009;124(5):1062-9.e1-4.
2009: John Koreth; Kristen E Stevenson; Haesook T Kim; Michael Garcia; Vincent T Ho; Philippe Armand; Corey Cutler; Jerome Ritz; Joseph H Antin; Robert J Soiffer; Edwin P Alyea
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors.
Blood 2009;114(18):3956-9.
2009: Vincent T Ho; Matthew Vanneman; Haesook Kim; Tetsuro Sasada; Yoon-Joong Kang; Mildred Pasek; Corey Cutler; John Koreth; Edwin P Alyea; Stefanie Sarantopoulos; Joseph H Antin; Jerome Ritz; Christine Canning; Jeffery Kutok; Martin C Mihm; Glenn Dranoff; Robert J Soiffer
Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(37):15825-30.
2009: Yi-Bin Chen; Haesook T Kim; Sean McDonough; Robert D Odze; Xiaopan Yao; Suzan Lazo-Kallanian; Thomas R Spitzer; Robert Soiffer; Joseph H Antin; Jerome Ritz
Up-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1066-76.
2009: Stefanie Sarantopoulos; Kristen E Stevenson; Haesook T Kim; Corey Cutler; Nazmim S Bhuiya; Michael Schowalter; Vincent T Ho; Edwin P Alyea; John Koreth; Bruce R Blazar; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.
Blood 2009;113(16):3865-74.
2009: Emmanuel Zorn; Mehrdad Mohseni; Haesook Kim; Fabrice Porcheray; Allison Lynch; Roberto Bellucci; Christine Canning; Edwin P Alyea; Robert J Soiffer; Jerome Ritz
Combined CD4+ donor lymphocyte infusion and low-dose recombinant IL-2 expand FOXP3+ regulatory T cells following allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(3):382-8.
2009: Catia Fonseca; Robert Soiffer; Vincent Ho; Matthew Vanneman; Masahisa Jinushi; Jerome Ritz; Donna Neuberg; Richard Stone; Dan DeAngelo; Glenn Dranoff
Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction.
Blood 2009;113(8):1681-8.
2008: Paul Armistead; Mehrdad Mohseni; Roslyn Gerwin; Emily C Walsh; Masoud Iravani; Bahram Chahardouli; Shahrbano Rostami; Wandi Zhang; Donna Neuberg; John Rioux; Ardeshir Ghavamzadeh; Jerome Ritz; Joseph H Antin; Catherine J Wu
Erythroid-lineage-specific engraftment in patients with severe hemoglobinopathy following allogeneic hematopoietic stem cell transplantation.
Experimental hematology 2008;36(9):1205-15.
2008: Shaun A Steigman; Myriam Armant; Lucy Bayer-Zwirello; Grace S Kao; Leslie Silberstein; Jerome Ritz; Dario O Fauza
Preclinical regulatory validation of a 3-stage amniotic mesenchymal stem cell manufacturing protocol.
Journal of pediatric surgery 2008;43(6):1164-9.
2008: Masahisa Jinushi; Matthew Vanneman; Nikhil C Munshi; Yu-Tzu Tai; Rao H Prabhala; Jerome Ritz; Donna Neuberg; Kenneth C Anderson; Daniel R Carrasco; Glenn Dranoff
MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(4):1285-90.
2008: Philippe Armand; Haesook T Kim; Corey Cutler; Vincent T Ho; John Koreth; Jerome Ritz; Edwin P Alyea; Joseph H Antin; Robert J Soiffer
A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(1):28-35.
2007: Catherine J Wu; Mark Gladwin; John Tisdale; Matthew Hsieh; Terence Law; Melinda Biernacki; Shelby Rogers; Xunde Wang; Mark Walters; David Zahrieh; Joseph H Antin; Jerome Ritz; Lakshamanan Krishnamurti
Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis.
British journal of haematology 2007;139(3):504-7.
2007: Stefanie Sarantopoulos; Kristen E Stevenson; Haesook T Kim; Nazmim S Bhuiya; Corey Cutler; Robert J Soiffer; Joseph H Antin; Jerome Ritz
High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(20):6107-14.
2007: Philippe Armand; Haesook T Kim; Daniel J DeAngelo; Vincent T Ho; Corey Cutler; Richard M Stone; Jerome Ritz; Edwin P Alyea; Joseph H Antin; Robert J Soiffer
Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(6):655-64.
2007: Sabina Chiaretti; Simona Tavolaro; Emanuela Ghia; Cristina Ariola; Caterina Matteucci; Loredana Elia; Roberta Maggio; Monica Messina; Maria R Ricciardi; Antonella Vitale; Jerome Ritz; Cristina Mecucci; Anna Guarini; Robin Foà
Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis.
Haematologica 2007;92(5):619-26.
2007: Roberto Bellucci; Sabine Oertelt; Meagan Gallagher; Sigui Li; Emmanuel Zorn; Edie Weller; Fabrice Porcheray; Edwin P Alyea; Robert J Soiffer; Nikhil C Munshi; M Eric Gershwin; Jerome Ritz
Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis.
Blood 2007;109(5):2001-7.
2007: Ann Mullally; Jerome Ritz
Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation.
Blood 2007;109(4):1355-62.
2006: Yupo Ma; Wei Cui; Jianchang Yang; Jun Qu; Chunhui Di; Hesham M Amin; Raymond Lai; Jerome Ritz; Diane S Krause; Li Chai
SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice.
Blood 2006;108(8):2726-35.
2006: Jennifer R Brown; Haesook T Kim; Shuli Li; Katherine Stephans; David C Fisher; Corey Cutler; Vincent T Ho; Stephanie J Lee; Edgar L Milford; Jerome Ritz; Joseph H Antin; Robert J Soiffer; John G Gribben; Edwin P Alyea
Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(10):1056-64.
2006: Edwin P Alyea; Haesook T Kim; Vincent T Ho; Corey Cutler; Daniel J DeAngelo; Richard M Stone; Jerome Ritz; Joseph H Antin; Robert J Soiffer
Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(10):1047-55.
2006: Emmanuel Zorn; Jerome Ritz
Studying human regulatory T cells in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5265-7.
2006: Emmanuel Zorn; Erik A Nelson; Mehrdad Mohseni; Fabrice Porcheray; Haesook T Kim; Despina Litsa; Roberto Bellucci; Elke Raderschall; Christine Canning; Robert J Soiffer; David A Frank; Jerome Ritz
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo.
Blood 2006;108(5):1571-9.
2006: Corey Cutler; David B Miklos; Haesook T Kim; Nathaniel S Treister; Sook-Bin Woo; Don Bienfang; Lloyd B Klickstein; Jesse Levin; Katherine Miller; Carol Reynolds; Rebecca Macdonell; Mildred Pasek; Stephanie J Lee; Vincent T Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz; Edwin P Alyea
Rituximab for steroid-refractory chronic graft-versus-host disease.
Blood 2006;108(2):756-62.
2006: Zubair Abba; Grace S Kao; Heather Daley; Daryls Schott; Arnold S Freedman; Jerome Ritz
CD34(+) CD38(-) and CD34(+) HLA-DR(-) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation.
Cytotherapy 2006;8(4):399-407.
2006: Catherine J Wu; Jerome Ritz
Induction of tumor immunity following allogeneic stem cell transplantation.
Advances in immunology 2006;90():133-73.
2006: Sabina Chiaretti; Anna Guarini; Maria Stefania De Propris; Simona Tavolaro; Stefania Intoppa; Antonella Vitale; Simona Iacobelli; Loredana Elia; Cristina Ariola; Jerome Ritz; Robin Foà
ZAP-70 expression in acute lymphoblastic leukemia: association with the E2A/PBX1 rearrangement and the pre-B stage of differentiation and prognostic implications.
Blood 2006;107(1):197-204.
2005: John G Gribben; David Zahrieh; Katherine Stephans; Lini Bartlett-Pandite; Edwin P Alyea; David C Fisher; Arnold S Freedman; Peter M Mauch; Robert Schlossman; Lecia V Sequist; Robert J Soiffer; Blossom Marshall; Donna Neuberg; Jerome Ritz; Lee M Nadler
Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia.
Blood 2005;106(13):4389-96.
2005: Catherine J Wu; Lakshamanan Krishnamurti; Jeffery L Kutok; Melinda Biernacki; Shelby Rogers; Wandi Zhang; Joseph H Antin; Jerome Ritz
Evidence for ineffective erythropoiesis in severe sickle cell disease.
Blood 2005;106(10):3639-45.
2005: Sabina Chiaretti; Xiaochun Li; Robert Gentleman; Antonella Vitale; Kathy S Wang; Franco Mandelli; Robin Foà; Jerome Ritz
Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(20):7209-19.
2005: Emmanuel Zorn; Haesook T Kim; Stephanie J Lee; Blair H Floyd; Despina Litsa; Sankari Arumugarajah; Roberto Bellucci; Edwin P Alyea; Joseph H Antin; Robert J Soiffer; Jerome Ritz
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.
Blood 2005;106(8):2903-11.
2005: M J Robertson; Richard S Schacterle; G A Mackin; S N Wilson; K L Bloomingdale; Jerome Ritz; Anthony L Komaroff
Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression.
Clinical and experimental immunology 2005;141(2):326-32.
2005: Giovanni F Torelli; Anna Guarini; Alessandra Porzia; Sabina Chiaretti; Caterina Tatarelli; Daniela Diverio; Roberta Maggio; Antonella Vitale; Jerome Ritz; Robin Foa
FLT3 inhibition in t(4;11)+ adult acute lymphoid leukaemia.
British journal of haematology 2005;130(1):43-50.
2005: Catherine J Wu; Melinda Biernacki; Jeffery L Kutok; Shelby Rogers; Linyun Chen; Xiao-Feng Yang; Robert J Soiffer; Jerome Ritz
Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(12):4504-11.
2005: Sabina Chiaretti; Jerome Ritz; Robin Foa
Genomic analysis in lymphoid leukemias.
Reviews in clinical and experimental hematology 2005;9(1):E3.
2005: Mahlet G Tadesse; Joseph G Ibrahim; Robert Gentleman; Sabina Chiaretti; Jerome Ritz; Robin Foa
Bayesian error-in-variable survival model for the analysis of GeneChip arrays.
Biometrics 2005;61(2):488-97.
2005: Roberto Bellucci; Edwin P Alyea; Sabina Chiaretti; Catherine J Wu; Emmanuel Zorn; Edie Weller; Bingyan Wu; Christine Canning; Robert Schlossman; Nikhil C Munshi; Kenneth C Anderson; Jerome Ritz
Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor.
Blood 2005;105(10):3945-50.
2005: David B Miklos; Haesook T Kim; Katherine H Miller; Luxuan Guo; Emmanuel Zorn; Stephanie J Lee; Ephraim P Hochberg; Catherine J Wu; Edwin P Alyea; Corey Cutler; Vincent T Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.
Blood 2005;105(7):2973-8.
2005: Edwin P Alyea; Haesook T Kim; Vincent T Ho; Corey Cutler; John G Gribben; Daniel J DeAngelo; Stephanie J Lee; Sarah Windawi; Jerome Ritz; Richard M Stone; Joseph H Antin; Robert J Soiffer
Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.
Blood 2005;105(4):1810-4.
2005: Jerome Ritz
Immune reconstitution after allogeneic stem cell transplantation.
Haematologica 2005;90(1):5.
2004: Vincent T Ho; David Zahrieh; Ephraim P Hochberg; Eileen Micale; Jesse Levin; Carol Reynolds; Steve Steckel; Corey Cutler; David C Fisher; Stephanie J Lee; Edwin P Alyea; Jerome Ritz; Robert J Soiffer; Joseph H Antin
Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Blood 2004;104(4):1224-6.
2004: Daniel J DeAngelo; Ephraim P Hochberg; Edwin P Alyea; Janina Longtine; Stephanie Lee; Ilene Galinsky; Ben Parekkedon; Jerome Ritz; Joseph H Antin; Richard M Stone; Robert J Soiffer
Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):5065-71.
2004: Emmanuel Zorn; David B Miklos; Blair H Floyd; Alex Mattes-Ritz; Luxuan Guo; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation.
The Journal of experimental medicine 2004;199(8):1133-42.
2004: Sabina Chiaretti; Xiaochun Li; Robert Gentleman; Antonella Vitale; Marco Vignetti; Franco Mandelli; Jerome Ritz; Robin Foa
Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival.
Blood 2004;103(7):2771-8.
2004: Zubair Abba; David Zahrieh; Heather Daley; Daryls Schott; John G Gribben; Edwin P Alyea; Robert Schlossman; Arnold S Freedman; Joseph H Antin; Robert J Soiffer; Donna Neuberg; Jerome Ritz
Engraftment of autologous and allogeneic marrow HPCs after myeloablative therapy.
Transfusion 2004;44(2):253-61.
2004: Roberto Bellucci; Catherine J Wu; Sabina Chiaretti; Edie Weller; Faith E Davies; Edwin P Alyea; Glenn Dranoff; Kenneth C Anderson; Nikhil C Munshi; Jerome Ritz
Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens.
Blood 2004;103(2):656-63.
2004: Daniel J DeAngelo; Jerome Ritz
Imatinib therapy for patients with chronic myelogenous leukemia: are patients living longer?
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):1-3.
2004: Yan Yan; Leuyen Phan; Fan Yang; Moshe Talpaz; Yu Yang; Zeyu Xiong; Bernard Ng; Nikolai A Timchenko; Catherine J Wu; Jerome Ritz; Hong Wang; Xiao-Feng Yang
A novel mechanism of alternative promoter and splicing regulates the epitope generation of tumor antigen CML66-L.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(1):651-60.
2004: David B Miklos; Haesook T Kim; Emmanuel Zorn; Ephraim P Hochberg; Luxuan Guo; Alex Mattes-Ritz; Sebastien Viatte; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.
Blood 2004;103(1):353-9.
2003: Edwin P Alyea; Edie Weller; Robert Schlossman; Christine Canning; Peter M Mauch; Andrea K Ng; David C Fisher; John G Gribben; Andrea Freeman; Bijal Parikh; Paul Richardson; Robert J Soiffer; Jerome Ritz; Kenneth C Anderson
Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect.
Bone marrow transplantation 2003;32(12):1145-51.
2003: Catherine J Wu; Ephraim P Hochberg; Shelby A Rogers; Jeffery L Kutok; Melinda Biernacki; Alessandra F Nascimento; Peter W Marks; Kenneth Bridges; Jerome Ritz
Molecular assessment of erythroid lineage chimerism following nonmyeloablative allogeneic stem cell transplantation.
Experimental hematology 2003;31(10):924-33.
2003: Enrica Orsini; Roberto Bellucci; Edwin P Alyea; Robert Schlossman; Christine Canning; Stephen McLaughlin; Paolo Ghia; Kenneth C Anderson; Jerome Ritz
Expansion of tumor-specific CD8+ T cell clones in patients with relapsed myeloma after donor lymphocyte infusion.
Cancer research 2003;63(10):2561-8.
2003: Zubair Abba; David Zahrieh; Heather Daley; Daryls Schott; John G Gribben; Arnold S Freedman; Jerome Ritz
Early neutrophil engraftment following autologous BMT provides a functional predictor of long-term hematopoietic reconstitution.
Transfusion 2003;43(5):614-21.
2003: Ephraim P Hochberg; David B Miklos; Donna Neuberg; Daniel A Eichner; Stephen F McLaughlin; Alex Mattes-Ritz; Edwin P Alyea; Joseph H Antin; Robert J Soiffer; Jerome Ritz
A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation.
Blood 2003;101(1):363-9.
2002: Catherine J Wu; Donna Neuberg; Antoinette Chillemi; Stephen McLaughlin; Ephraim P Hochberg; Ilene Galinsky; Daniel J DeAngelo; Robert J Soiffer; Edwin P Alyea; Renaud Capdeville; Richard M Stone; Jerome Ritz
Quantitative monitoring of BCR/ABL transcript during STI-571 therapy.
Leukemia & lymphoma 2002;43(12):2281-9.
2002: Xiao-Feng Yang; Catherine J Wu; Linyun Chen; Edwin P Alyea; Christine Canning; Philip W Kantoff; Robert J Soiffer; Glenn Dranoff; Jerome Ritz
CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.
Cancer research 2002;62(19):5517-22.
2002: Roberto Bellucci; Jerome Ritz
Allogeneic stem cell transplantation for multiple myeloma.
Reviews in clinical and experimental hematology 2002;6(3):205-24.
2002: Zubair Abba; Leslie Silberstein; Jerome Ritz
Adult hematopoietic stem cell plasticity.
Transfusion 2002;42(8):1096-101.
2002: Emmanuel Zorn; Kathy S Wang; Ephraim P Hochberg; Christine Canning; Edwin P Alyea; Robert J Soiffer; Jerome Ritz
Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2052-60.
2002: Ugo Testa; Giovanni F Torelli; Roberta Riccioni; Andrea Onetti Muta; Stefania Militi; Luciana Annino; Gualtiero Mariani; Anna Guarini; Sabina Chiaretti; Jerome Ritz; Franco Mandelli; Cesare Peschle; Robin Foa
Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptors.
Blood 2002;99(12):4634-7.
2002: Roberto Bellucci; Edwin P Alyea; Edie Weller; Antoinette Chillemi; Ephraim P Hochberg; Catherine J Wu; Christine Canning; Robert Schlossman; Robert J Soiffer; Kenneth C Anderson; Jerome Ritz
Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma.
Blood 2002;99(12):4610-7.
2002: Jonathan W Friedberg; Donna Neuberg; John G Gribben; David C Fisher; Christine Canning; Margaret Koval; Christine M Poor; Luke M Green; John Daley; Robert J Soiffer; Jerome Ritz; Arnold S Freedman
Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non-Hodgkin's lymphoma.
British journal of haematology 2002;117(4):828-34.
2002: F Stephen Hodi; Jan C Schmollinger; Robert J Soiffer; Ravi Salgia; Thomas J Lynch; Jerome Ritz; Edwin P Alyea; Jihong Yang; Donna Neuberg; Martin Mihm; Glenn Dranoff
ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(10):6919-24.
2002: Mohamed H Zaki; Maria Wysocka; Suzanne E Everetts; Kathy S Wang; Lars E French; Jerome Ritz; Alain H Rook
Synergistic enhancement of cell-mediated immunity by interleukin-12 plus interleukin-2: basis for therapy of cutaneous T cell lymphoma.
The Journal of investigative dermatology 2002;118(2):366-71.
2002: Robert J Soiffer; Edwin P Alyea; Ephraim P Hochberg; Catherine Wu; Christine Canning; Bijal Parikh; David Zahrieh; Iain Webb; Joseph H Antin; Jerome Ritz
Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(11):625-32.
2002: Edwin P Alyea; Donna Neuberg; Peter M Mauch; Karen Marcus; Arnold S Freedman; Iain Webb; Kenneth C Anderson; Robert Schlossman; David C Fisher; John G Gribben; Jerome Ritz; Robert J Soiffer
Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(3):139-44.
2001: Ephraim P Hochberg; Antoinette Chillemi; Catherine J Wu; Donna Neuberg; Christine Canning; K Hartman; Edwin P Alyea; Robert J Soiffer; Spyros A Kalams; Jerome Ritz
Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults.
Blood 2001;98(4):1116-21.
2001: Edwin P Alyea; Edie Weller; Robert Schlossman; Christine Canning; Iain Webb; Deborah Doss; Peter M Mauch; Karen Marcus; David C Fisher; Andrea Freeman; Bijal Parikh; John G Gribben; Robert J Soiffer; Jerome Ritz; Kenneth C Anderson
T-cell--depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect.
Blood 2001;98(4):934-9.
2001: Xiao-Feng Yang; Catherine J Wu; Stephen McLaughlin; Antoinette Chillemi; K S Wang; Christine Canning; Edwin P Alyea; Philip W Kantoff; Robert J Soiffer; Glenn Dranoff; Jerome Ritz
CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(13):7492-7.
2001: K S Wang; Emmanuel Zorn; Jerome Ritz
Specific down-regulation of interleukin-12 signaling through induction of phospho-STAT4 protein degradation.
Blood 2001;97(12):3860-6.
2001: Emmanuel Zorn; Enrica Orsini; Catherine J Wu; B Stein; Antoinette Chillemi; Christine Canning; Edwin P Alyea; Robert J Soiffer; Jerome Ritz
A CD4+ T cell clone selected from a CML patient after donor lymphocyte infusion recognizes BCR-ABL breakpoint peptides but not tumor cells.
Transplantation 2001;71(8):1131-7.
2001: Robert J Soiffer; Edie Weller; Edwin P Alyea; Peter M Mauch; I L Webb; David C Fisher; Arnold S Freedman; Robert Schlossman; John G Gribben; Sandra Lee; Kenneth C Anderson; Karen Marcus; Richard M Stone; Joseph H Antin; Jerome Ritz
CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1152-9.
2001: Sudipta Mahajan; JA Gollob; Jerome Ritz; David A Frank
CD2 stimulation leads to the delayed and prolonged activation of STAT1 in T cells but not NK cells.
Experimental hematology 2001;29(2):209-20.
2000: Catherine J Wu; Xiao-Feng Yang; Stephen McLaughlin; Donna Neuberg; C Canning; B Stein; Edwin P Alyea; Robert J Soiffer; Glenn Dranoff; Jerome Ritz
Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia.
The Journal of clinical investigation 2000;106(5):705-14.
2000: K S Wang; David A Frank; Jerome Ritz
Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4.
Blood 2000;95(10):3183-90.
2000: Enrica Orsini; Edwin P Alyea; Robert Schlossman; Christine Canning; Robert J Soiffer; Antoinette Chillemi; Donna Neuberg; Kenneth C Anderson; Jerome Ritz
Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion.
Bone marrow transplantation 2000;25(6):623-32.
2000: Enrica Orsini; Edwin P Alyea; Antoinette Chillemi; Robert Schlossman; Stephen McLaughlin; Christine Canning; Robert J Soiffer; Kenneth C Anderson; Jerome Ritz
Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(4):375-86.
2000: Catherine J Wu; Antoinette Chillemi; Edwin P Alyea; Enrica Orsini; Donna Neuberg; Robert J Soiffer; Jerome Ritz
Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism.
Blood 2000;95(1):352-9.
1999: Arnold S Freedman; Donna Neuberg; Peter M Mauch; Robert J Soiffer; Kenneth C Anderson; David C Fisher; Robert Schlossman; Edwin P Alyea; Tak Takvorian; Haddy Jallow; C Kuhlman; Jerome Ritz; Lee M Nadler; John G Gribben
Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma.
Blood 1999;94(10):3325-33.
1999: Jonathan W Friedberg; Donna Neuberg; Richard M Stone; Edwin P Alyea; Haddy Jallow; Ann S LaCasce; Peter M Mauch; John G Gribben; Jerome Ritz; Lee M Nadler; Robert J Soiffer; Arnold S Freedman
Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3128-35.
1999: Francisco Borrego; M J Robertson; Jerome Ritz; José Peña; Rafael Solana
CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor.
Immunology 1999;97(1):159-65.
1999: JA Gollob; CP Schnipper; E A Murphy; Jerome Ritz; David A Frank
The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(8):4472-81.
1999: David A Frank; Sudipta Mahajan; Jerome Ritz
Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling.
Nature medicine 1999;5(4):444-7.
1999: L H Sehn; Edwin P Alyea; Edie Weller; Christine Canning; Sandra Lee; Jerome Ritz; Joseph H Antin; Robert J Soiffer
Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):561-8.
1999: Patricia Dahia; Ricardo Aguiar; John A Alberta; JB Kum; S Caron; Heinz Sill; Deborah J Marsh; Jerome Ritz; Arnold S Freedman; Charles D Stiles; Charis Eng
PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies.
Human molecular genetics 1999;8(2):185-93.
1999: Jonathan W Friedberg; Donna Neuberg; John G Gribben; Peter M Mauch; Kenneth C Anderson; Robert J Soiffer; Tak Takvorian; David C Fisher; Robert Schlossman; Haddy Jallow; C Kuhlman; Jerome Ritz; Arnold S Freedman
Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(4):262-8.
1999: Michael J Robertson; C Cameron; Michael B Atkins; Michael S Gordon; M T Lotze; Matthew L Sherman; Jerome Ritz
Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(1):9-16.
1999: K S Wang; Jerome Ritz; David A Frank
IL-2 induces STAT4 activation in primary NK cells and NK cell lines, but not in T cells.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(1):299-304.
1998: S J Lee; Edie Weller; Edwin P Alyea; Jerome Ritz; Robert J Soiffer
Efficacy and costs of granulocyte colony-stimulating factor in allogeneic T-cell depleted bone marrow transplantation.
Blood 1998;92(8):2725-9.
1998: Denis David; L Bani; Jean-Louis Moreau; Marie-Pierre Treilhou; T Nakarai; Marcel Joussemet; Jerome Ritz; Bertrand Dupont; Gilles Pialoux; Jacques Thèze
Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(19):11348-53.
1998: Denis David; L Bani; Jean-Louis Moreau; Marie-Pierre Treilhou; C Demaison; K Sun; Michèle Février; O Salvucci; Alfonso Cayota; T Nakarai; S Chouaïb; M de Montalembert; Marcel Joussemet; K Sugamura; Jerome Ritz; Bertrand Dupont; Gilles Pialoux; Jacques Thèze
Dysregulation of interleukin-2 receptor beta and interleukin-2 receptor gamma expression during HIV infection.
European cytokine network 1998;9(3 Suppl):97-101.
1998: JA Gollob; CP Schnipper; E Orsini; E Murphy; J F Daley; S B Lazo; David A Frank; Donna Neuberg; Jerome Ritz
Characterization of a novel subset of CD8(+) T cells that expands in patients receiving interleukin-12.
The Journal of clinical investigation 1998;102(3):561-75.
1998: Eric Delabesse; M Bernard; V Meyer; L Smit; Karen Pulford; Jean-Michel Cayuela; Jerome Ritz; P Bourquelot; Jack L Strominger; Françoise Valensi; Elizabeth Macintyre
TAL1 expression does not occur in the majority of T-ALL blasts.
British journal of haematology 1998;102(2):449-57.
1998: Robert J Soiffer; Arnold S Freedman; Donna Neuberg; David C Fisher; Edwin P Alyea; John G Gribben; Robert Schlossman; Lini Bartlett-Pandite; C Kuhlman; C Murray; Andrea Freeman; Peter M Mauch; Kenneth C Anderson; Lee M Nadler; Jerome Ritz
CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.
Bone marrow transplantation 1998;21(12):1177-81.
1998: Edwin P Alyea; Robert J Soiffer; Christine Canning; Donna Neuberg; Robert Schlossman; C Pickett; H Collins; Yanfeng Wang; Kenneth C Anderson; Jerome Ritz
Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant.
Blood 1998;91(10):3671-80.
1998: C Barzegar; Raffaella Meazza; R Pereno; C Pottin-Clemenceau; Marco Scudeletti; Danièle Brouty-Boyé; Chantal Doucet; Yassine Taoufik; Jerome Ritz; C Musselli; Zohar Mishal; Claude Jasmin; Francesco Indiveri; Silvano Ferrini; Bruno Azzarone
IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops.
Oncogene 1998;16(19):2503-12.
1998: SD Voss; J Daley; Jerome Ritz; M J Robertson
Participation of the CD94 receptor complex in costimulation of human natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(4):1618-26.
1998: JA Gollob; E A Murphy; Sudipta Mahajan; CP Schnipper; Jerome Ritz; David A Frank
Altered interleukin-12 responsiveness in Th1 and Th2 cells is associated with the differential activation of STAT5 and STAT1.
Blood 1998;91(4):1341-54.
1998: Arnold S Freedman; Donna Neuberg; John G Gribben; Peter M Mauch; Robert J Soiffer; David C Fisher; Kenneth C Anderson; N Andersen; Robert Schlossman; M Kroon; Jerome Ritz; Jon C Aster; Lee M Nadler
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):13-8.
1998: Denis David; L Bani; Jean-Louis Moreau; C Demaison; K Sun; O Salvucci; T Nakarai; M de Montalembert; S Chouaïb; Marcel Joussemet; Jerome Ritz; Jacques Thèze
Further analysis of interleukin-2 receptor subunit expression on the different human peripheral blood mononuclear cell subsets.
Blood 1998;91(1):165-72.
1997: David A Frank; Sudipta Mahajan; Jerome Ritz
B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues.
The Journal of clinical investigation 1997;100(12):3140-8.
1997: Arnold S Freedman; Donna Neuberg; Peter M Mauch; John G Gribben; Robert J Soiffer; Kenneth C Anderson; M Robertson; David C Fisher; Robert Schlossman; M Kroon; C Rhuda; C Kuhlman; Jerome Ritz; Lee M Nadler
Cyclophosphamide, doxorubicin, vincristine, prednisone dose intensification with granulocyte colony-stimulating factor markedly depletes stem cell reserve for autologous bone marrow transplantation.
Blood 1997;90(12):4996-5001.
1997: T Sato; Y Ohashi; K Tachibana; Robert J Soiffer; Jerome Ritz; Chikao Morimoto
Altered tyrosine phosphorylation via the very late antigen (VLA)/beta1 integrin stimulation is associated with impaired T-cell signaling through VLA-4 after allogeneic bone marrow transplantation.
Blood 1997;90(10):4222-9.
1997: Iain Webb; Robert J Soiffer; J W Andersen; C A Cohen; Andrea Freeman; M Sugrue; Jerome Ritz; Kenneth C Anderson
In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(5):267-72.
1997: Daniel J Weisdorf; Amy L Billett; P Hannan; Jerome Ritz; Stephen E Sallan; Michael Steinbuch; Norma K C Ramsay
Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia.
Blood 1997;90(8):2962-8.
1997: Vladimir Kolenko; Q Wang; M C Riedy; John O'Shea; Jerome Ritz; Martha K Cathcart; Patricia Rayman; Raymond Tubbs; MG Edinger; Andrew C Novick; Ronald Bukowski; James Finke
Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(6):3057-67.
1997: H Ida; M J Robertson; S Voss; Jerome Ritz; Paul Anderson
CD94 ligation induces apoptosis in a subset of IL-2-stimulated NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(5):2154-60.
1997: E J Claret; Edwin P Alyea; Enrica Orsini; C C Pickett; H Collins; Yanfeng Wang; Donna Neuberg; Robert J Soiffer; Jerome Ritz
Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion.
The Journal of clinical investigation 1997;100(4):855-66.
1997: D Wang; Gordon J Freeman; H Levine; Jerome Ritz; M J Robertson
Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
British journal of haematology 1997;97(2):409-17.
1997: Robert J Soiffer; DL Fairclough; M Robertson; Edwin P Alyea; Kenneth C Anderson; Arnold S Freedman; Lini Bartlett-Pandite; David C Fisher; Robert Schlossman; R Stone; C Murray; Andrea Freeman; Karen Marcus; Peter M Mauch; Lee M Nadler; Jerome Ritz
CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission.
Blood 1997;89(8):3039-47.
1997: Robert J Soiffer; Peter M Mauch; DL Fairclough; Edwin P Alyea; Kenneth C Anderson; David C Fisher; Arnold S Freedman; Lini Bartlett-Pandite; M Robertson; Robert Schlossman; JA Gollob; Karen Marcus; C Murray; C Kuhlman; Andrea Freeman; Lee M Nadler; Jerome Ritz
CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(1):11-7.
1997: L Bani; Denis David; Jean-Louis Moreau; Alfonso Cayota; T Nakarai; Jerome Ritz; Jacques Thèze
Expression of the IL-2 receptor gamma subunit in resting human CD4 T lymphocytes: mRNA is constitutively transcribed and the protein stored as an intracellular component.
International immunology 1997;9(4):573-80.
1997: Michael B Atkins; Michael J Robertson; Michael S Gordon; M T Lotze; M DeCoste; J S DuBois; Jerome Ritz; Alan B Sandler; H D Edington; P D Garzone; James W Mier; C M Canning; L Battiato; H Tahara; Matthew L Sherman
Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(3):409-17.
1997: J A Gollob; H Kawasaki; Jerome Ritz
Interferon-gamma and interleukin-4 regulate T cell interleukin-12 responsiveness through the differential modulation of high-affinity interleukin-12 receptor expression.
European journal of immunology 1997;27(3):647-52.
1997: Thomas J Lynch; JM Lambert; F Coral; J Shefner; Patrick Y Wen; W A Blattler; A R Collinson; P D Ariniello; G Braman; S Cook; Dixie Esseltine; A Elias; Arthur T Skarin; Jerome Ritz
Immunotoxin therapy of small-cell lung cancer: a phase I study of N901-blocked ricin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):723-34.
1997: Robert J Soiffer; Paul B Chapman; C Murray; L Williams; P Unger; H Collins; Alan N Houghton; Jerome Ritz
Administration of R24 monoclonal antibody and low-dose interleukin 2 for malignant melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(1):17-24.
1996: Thomas Williams McLean; S Ringold; Donna Neuberg; Kimberly Stegmaier; R Tantravahi; Jerome Ritz; H P Koeffler; S Takeuchi; Johannes W G Janssen; Taku Seriu; Claus R Bartram; Stephen E Sallan; D Gary Gilliland; Todd R Golub
TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia.
Blood 1996;88(11):4252-8.
1996: E A Vance; Robert J Soiffer; G B McDonald; D Myerson; Joyce Diane Fingeroth; Jerome Ritz
Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon.
Transplantation 1996;62(9):1358-60.
1996: JA Gollob; Jerome Ritz
CD2-CD58 interaction and the control of T-cell interleukin-12 responsiveness. Adhesion molecules link innate and acquired immunity.
Annals of the New York Academy of Sciences 1996;795():71-81.
1996: Arnold S Freedman; John G Gribben; Donna Neuberg; Peter M Mauch; Robert J Soiffer; Kenneth C Anderson; L Pandite; M J Robertson; M Kroon; Jerome Ritz; Lee M Nadler
High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission.
Blood 1996;88(7):2780-6.
1996: C Pignata; J S Sanghera; Robert J Soiffer; S Chartier; M Eder; S L Pelech; Jerome Ritz
Defective activation of mitogen-activated protein kinase after allogeneic bone marrow transplantation.
Blood 1996;88(6):2334-41.
1996: D Provan; Lini Bartlett-Pandite; C Zwicky; Donna Neuberg; A Maddocks; Paolo Corradini; Robert J Soiffer; Jerome Ritz; Lee M Nadler; John G Gribben
Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation.
Blood 1996;88(6):2228-35.
1996: Iain Webb; F S Coral; J W Andersen; Anthony D Elias; R W Finberg; Lee M Nadler; Jerome Ritz; Kenneth C Anderson
Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering.
Transfusion 1996;36(9):782-8.
1996: Vassiliki A Boussiotis; N A Pardo; H Collins; Alan N Houghton; Jerome Ritz; Lee M Nadler; Robert J Soiffer
R24 anti-GD3 ganglioside antibody can induce costimulation and prevent the induction of alloantigen-specific T cell clonal anergy.
European journal of immunology 1996;26(9):2149-54.
1996: JA Gollob; J Li; H Kawasaki; J F Daley; C Groves; Ellis L Reinherz; Jerome Ritz
Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(5):1886-93.
1996: M Ernst; H Stein; D Ludwig; J Boese-Landgraf; Jerome Ritz; R Häring
Surgical therapy of gastrointestinal non-Hodgkin's lymphomas.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1996;22(2):177-81.
1996: Ralf R Schumann; T Nakarai; HJ Gruss; M A Brach; U von Arnim; Carsten J Kirschning; Leonid Karawajew; Wolf-Dieter Ludwig; J C Renauld; Jerome Ritz; F Herrmann
Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gamma-chain) by normal and malignant myeloid cells.
Blood 1996;87(6):2419-27.
1996: Robert J Soiffer; C Murray; C Shapiro; H Collins; S Chartier; S Lazo; Jerome Ritz
Expansion and manipulation of natural killer cells in patients with metastatic cancer by low-dose continuous infusion and intermittent bolus administration of interleukin 2.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(3):493-9.
1996: Mary-Ellen Taplin; M E Frantz; C Canning; Jerome Ritz; Richard S Blumberg; S P Balk
Evidence against T-cell development in the adult human intestinal mucosa based upon lack of terminal deoxynucleotidyltransferase expression.
Immunology 1996;87(3):402-7.
1996: P L Nguyen; N L Harris; Jerome Ritz; M J Robertson
Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
The American journal of pathology 1996;148(3):847-53.
1996: M J Robertson; K J Cochran; C Cameron; J M Le; R Tantravahi; Jerome Ritz
Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
Experimental hematology 1996;24(3):406-15.
1996: M J Robertson; C Cameron; S Lazo; K J Cochran; S D Voss; Jerome Ritz
Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
Natural immunity 1996;15(5):213-26.
1995: C Pignata; Kanteti V Prasad; Michael Hallek; Brian J Druker; Christopher E Rudd; M J Robertson; Jerome Ritz
Phosphorylation of src family lck tyrosine kinase following interleukin-12 activation of human natural killer cells.
Cellular immunology 1995;165(2):211-6.
1995: JA Gollob; J Li; Ellis L Reinherz; Jerome Ritz
CD2 regulates responsiveness of activated T cells to interleukin 12.
The Journal of experimental medicine 1995;182(3):721-31.
1995: David A Frank; M J Robertson; Azad Bonni; Jerome Ritz; Michael E Greenberg
Interleukin 2 signaling involves the phosphorylation of Stat proteins.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(17):7779-83.
1995: Michael Seiden; Robert Schlossman; J Andersen; Andrea Freeman; M Robertson; Robert J Soiffer; Arnold S Freedman; Peter M Mauch; Jerome Ritz; Lee M Nadler
Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma.
Leukemia & lymphoma 1995;17(1-2):87-93.
1995: M J Robertson; T J Manley; G Pichert; C Cameron; K J Cochran; H Levine; Jerome Ritz
Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells.
Leukemia & lymphoma 1995;17(1-2):51-61.
1995: Robert J Soiffer; C Murray; Jerome Ritz; N Phillips; D Jacobsohn; S Chartier; Donna M Ambrosino
Recombinant interleukin-2 infusions and decreased IgG2 subclass concentrations.
Blood 1995;85(4):925-8.
1995: J Kameoka; T Sato; Y Torimoto; K Sugita; Robert J Soiffer; Stuart F Schlossman; Jerome Ritz; Chikao Morimoto
Differential CD26-mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantation.
Blood 1995;85(4):1132-7.
1995: Robert J Soiffer; Edwin P Alyea; Jerome Ritz
Immunomodulatory effects of donor lymphocyte infusions following allogeneic bone marrow transplantation.
Journal of clinical apheresis 1995;10(3):139-43.
1995: M A Lew; K Kehoe; Jerome Ritz; Karen Antman; Lee M Nadler; L A Kalish; R Finberg
Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):239-50.
1995: Denis-Claude Roy; Claude Perreault; Robert Bélanger; M Gyger; C Le Houillier; W A Blättler; J M Lambert; Jerome Ritz
Elimination of B-lineage leukemia and lymphoma cells from bone marrow grafts using anti-B4-blocked-ricin immunotoxin.
Journal of clinical immunology 1995;15(1):51-7.
1994: Vassiliki A Boussiotis; Dwayne Barber; T Nakarai; Gordon J Freeman; John G Gribben; G M Bernstein; Alan D D'Andrea; Jerome Ritz; Lee M Nadler
Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor.
Science (New York, N.Y.) 1994;266(5187):1039-42.
1994: G Pichert; Edwin P Alyea; Robert J Soiffer; Denis-Claude Roy; Jerome Ritz
Persistence of myeloid progenitor cells expressing BCR-ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Blood 1994;84(7):2109-14.
1994: Peter A Burke; C M Canning; S Chartier; S Lazo; J Daley; R Armour Forse; Jerome Ritz
Alterations in Ca2+ signal transduction in critically ill surgical patients.
Surgery 1994;116(2):378-86; discussion 386-7.
1994: Robert J Soiffer; C Murray; R Gonin; Jerome Ritz
Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation.
Blood 1994;84(3):964-71.
1994: K Sugita; Y Nojima; K Tachibana; Robert J Soiffer; C Murray; Stuart F Schlossman; Jerome Ritz; Chikao Morimoto
Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantation.
The Journal of clinical investigation 1994;94(2):481-8.
1994: T Nakarai; M J Robertson; Michel Streuli; Z Wu; T L Ciardelli; Kendall A Smith; Jerome Ritz
Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells.
The Journal of experimental medicine 1994;180(1):241-51.
1994: K Sugita; Robert J Soiffer; C Murray; Stuart F Schlossman; Jerome Ritz; Chikao Morimoto
The phenotype and reconstitution of immunoregulatory T cell subsets after T cell-depleted allogeneic and autologous bone marrow transplantation.
Transplantation 1994;57(10):1465-73.
1994: T R Klumpp; D Fairclough; Jerome Ritz; Robert J Soiffer
The effect of minor ABO mismatches on the incidence of graft-versus-host disease after allogeneic bone marrow transplantation.
Transplantation 1994;57(5):780.
1994: S F Schlossman; Laurence Boumsell; W Gilks; J M Harlan; T Kishimoto; C Morimoto; Jerome Ritz; S Shaw; R L Silverstein; T A Springer
CD antigens 1993.
Immunology today 1994;15(3):98-9.
1994: Stuart F Schlossman; Laurence Boumsell; W Gilks; J M Harlan; T Kishimoto; Chikao Morimoto; Jerome Ritz; S Shaw; R L Silverstein; Timothy A Springer
CD antigens 1993.
Blood 1994;83(4):879-80.
1994: Jerome Ritz
Tumor immunity: will new keys unlock the door?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(2):237-8.
1994: G D McIntyre; C F Scott; Jerome Ritz; W A Blättler; J M Lambert
Preparation and characterization of interleukin-2-gelonin conjugates made using different cross-linking reagents.
Bioconjugate chemistry 1994;5(1):88-97.
1994: M J Robertson; Jerome Ritz
Prognostic significance of the surface antigens expressed by leukemic cells.
Leukemia & lymphoma 1994;13 Suppl 1():15-22.
1994: C Pignata; J S Sanghera; L Cossette; S L Pelech; Jerome Ritz
Interleukin-12 induces tyrosine phosphorylation and activation of 44-kD mitogen-activated protein kinase in human T cells.
Blood 1994;83(1):184-90.
1994: Stuart F Schlossman; Laurence Boumsell; W Gilks; J M Harlan; T Kishimoto; Chikao Morimoto; Jerome Ritz; S Shaw; R L Silverstein; Timothy A Springer
CD antigens 1993.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(1):1-2.
1994: M J Robertson; Denis-Claude Roy; Richard M Stone; Jerome Ritz
Use of CD33 monoclonal antibodies in bone marrow transplantation for acute myeloid leukemia.
Progress in clinical and biological research 1994;389():47-63.
1994: C Epstein; Thomas J Lynch; J Shefner; P Wen; D Maxted; V Braman; P Ariniello; F Coral; Jerome Ritz
Use of the immunotoxin N901-blocked ricin in patients with small-cell lung cancer.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1994;8():57-9.
1993: C Pignata; Kanteti V Prasad; M J Robertson; H Levine; Christopher E Rudd; Jerome Ritz
Fc gamma RIIIA-mediated signaling involves src-family lck in human natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(12):6794-800.
1993: Robert J Soiffer; M J Robertson; C Murray; K Cochran; Jerome Ritz
Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies.
Blood 1993;82(9):2790-6.
1993: G Pichert; Jerome Ritz
Clinical significance of bcr-abl gene rearrangement detected by the polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia.
Leukemia & lymphoma 1993;10(1-2):1-8.
1993: Amy L Billett; E Kornmehl; Nancy J Tarbell; Howard J Weinstein; Richard D Gelber; Jerome Ritz; Stephen E Sallan
Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia.
Blood 1993;81(6):1651-7.
1993: M J Robertson; T J Manley; C Donahue; H Levine; Jerome Ritz
Costimulatory signals are required for optimal proliferation of human natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(5):1705-14.
1993: Robert J Soiffer; Jerome Ritz
Selective T cell depletion of donor allogeneic marrow with anti-CD6 monoclonal antibody: rationale and results.
Bone marrow transplantation 1993;12 Suppl 3():S7-10.
1992: E A Macintyre; L Smit; Jerome Ritz; I R Kirsch; Jack L Strominger
Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor alpha beta lineage.
Blood 1992;80(6):1511-20.
1992: K Sugita; M J Robertson; Y Torimoto; Jerome Ritz; Stuart F Schlossman; Chikao Morimoto
Participation of the CD27 antigen in the regulation of IL-2-activated human natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1992;149(4):1199-203.
1992: T R Klumpp; C C Block; M A Caligiuri; S N Rabinowe; Robert J Soiffer; Jerome Ritz
Immune-mediated cytopenia following bone marrow transplantation. Case reports and review of the literature.
Medicine 1992;71(2):73-83.
1992: M J Robertson; Robert J Soiffer; Stanley Wolf; T J Manley; C Donahue; D Young; S H Herrmann; Jerome Ritz
Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.
The Journal of experimental medicine 1992;175(3):779-88.
1992: Michael L Grossbard; Arnold S Freedman; Jerome Ritz; F Coral; Victor S Goldmacher; L Eliseo; N Spector; K Dear; J M Lambert; W A Blättler
Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion.
Blood 1992;79(3):576-85.
1992: Robert J Soiffer; C Murray; K Cochran; C Cameron; E Wang; P W Schow; J F Daley; Jerome Ritz
Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation.
Blood 1992;79(2):517-26.
1992: B Tycko; Jerome Ritz; Stephen E Sallan; Jeffrey Sklar
Changing antigen receptor gene rearrangements in a case of early pre-B cell leukemia: evidence for a tumor progenitor cell with stem cell features and implications for monitoring residual disease.
Blood 1992;79(2):481-8.
1992: D M Baume; M J Robertson; H Levine; T J Manley; P W Schow; Jerome Ritz
Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells.
European journal of immunology 1992;22(1):1-6.
1991: Robert J Soiffer; K Dear; S N Rabinowe; Kenneth C Anderson; Arnold S Freedman; C Murray; Nancy J Tarbell; Peter M Mauch; Lee M Nadler; Jerome Ritz
Hepatic dysfunction following T-cell-depleted allogeneic bone marrow transplantation.
Transplantation 1991;52(6):1014-9.
1991: R Delage; Robert J Soiffer; K Dear; Jerome Ritz
Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia.
Blood 1991;78(10):2759-67.
1991: M J Robertson; Mark A Socinski; Robert J Soiffer; R W Finberg; C Wilson; Kenneth C Anderson; L Bosserman; D N Sang; I F Salkin; Jerome Ritz
Successful treatment of disseminated Fusarium infection after autologous bone marrow transplantation for acute myeloid leukemia.
Bone marrow transplantation 1991;8(2):143-5.
1991: Arnold S Freedman; Jerome Ritz; Donna Neuberg; Kenneth C Anderson; S N Rabinowe; Peter M Mauch; Tak Takvorian; Robert J Soiffer; K Blake; B Yeap
Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma.
Blood 1991;77(11):2524-9.
1991: Denis-Claude Roy; James D Griffin; M Belvin; W A Blättler; J M Lambert; Jerome Ritz
Anti-MY9-blocked-ricin: an immunotoxin for selective targeting of acute myeloid leukemia cells.
Blood 1991;77(11):2404-12.
1991: M D Blomquist; M Boggards; I Celine Hanson; Howard M Rosenblatt; M S Pollack; Edith Hawkins; Jerome Ritz; William T Shearer
Monoclonal anti-T cell (T12) antibody treatment of graft-versus-host disease in severe combined immunodeficiency: targeting of antibody and activation of complement on CD8+ cytotoxic T cell surfaces.
The Journal of allergy and clinical immunology 1991;87(5):1029-33.
1991: M A Lew; K Kehoe; Jerome Ritz; Karen Antman; Lee M Nadler; Tak Takvorian; R Mayer; L Kalish; R Finberg
Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation.
Transplantation 1991;51(3):630-6.
1991: Kenneth C Anderson; B A Barut; Jerome Ritz; Arnold S Freedman; Tak Takvorian; S N Rabinowe; Robert J Soiffer; L Heflin; F Coral; K Dear
Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma.
Blood 1991;77(4):712-20.
1990: M J Robertson; Jerome Ritz
Biology and clinical relevance of human natural killer cells.
Blood 1990;76(12):2421-38.
1990: D M Baume; M A Caligiuri; T J Manley; J F Daley; Jerome Ritz
Differential expression of CD8 alpha and CD8 beta associated with MHC-restricted and non-MHC-restricted cytolytic effector cells.
Cellular immunology 1990;131(2):352-65.
1990: T R Klumpp; M A Caligiuri; S N Rabinowe; Robert J Soiffer; C Murray; Jerome Ritz; M A Caliguri
Autoimmune pancytopenia following allogeneic bone marrow transplantation.
Bone marrow transplantation 1990;6(6):445-7.
1990: M J Robertson; M A Caligiuri; T J Manley; H Levine; Jerome Ritz
Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(10):3194-201.
1990: Maxine Jochelson; Nancy J Tarbell; Arnold S Freedman; S N Rabinowe; Tak Takvorian; Robert J Soiffer; Kenneth C Anderson; Jerome Ritz; Lee M Nadler
Acute and chronic pulmonary complications following autologous bone marrow transplantation in non-Hodgkin's lymphoma.
Bone marrow transplantation 1990;6(5):329-31.
1990: Robert J Soiffer; L Bosserman; C Murray; K Cochran; J Daley; Jerome Ritz
Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation.
Blood 1990;75(10):2076-84.
1990: M A Caligiuri; A Zmuidzinas; T J Manley; H Levine; Kendall A Smith; Jerome Ritz
Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors.
The Journal of experimental medicine 1990;171(5):1509-26.
1990: R Delage; Jerome Ritz; Kenneth C Anderson
The evolving role of bone marrow transplantation in the treatment of chronic myelogenous leukemia.
Hematology/oncology clinics of North America 1990;4(2):369-88.
1990: Paul Anderson; M Caligiuri; C O'Brien; T Manley; Jerome Ritz; Stuart F Schlossman
Fc gamma receptor type III (CD16) is included in the zeta NK receptor complex expressed by human natural killer cells.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(6):2274-8.
1990: D C Roy; M Felix; W G Cannady; S Cannistra; Jerome Ritz
Comparative activities of rabbit complements of different ages using an in-vitro marrow purging model.
Leukemia research 1990;14(5):407-16.
1990: Denis-Claude Roy; R Tantravahi; C Murray; K Dear; B Gorgone; Kenneth C Anderson; Arnold S Freedman; Lee M Nadler; Jerome Ritz
Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium.
Blood 1990;75(1):296-304.
1989: A Pedrazzini; Arnold S Freedman; J Andersen; L Heflin; Kenneth C Anderson; Tak Takvorian; George P Canellos; J Whitman; F Coral; Jerome Ritz
Anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: phenotypic reconstitution and B-cell function.
Blood 1989;74(6):2203-11.
1989: L Young; C Alfieri; K Hennessy; H Evans; C O'Hara; Kenneth C Anderson; Jerome Ritz; R S Shapiro; Alan B Rickinson; Elliott Kieff
Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.
The New England journal of medicine 1989;321(16):1080-5.
1989: Paul Anderson; M Caligiuri; Jerome Ritz; Stuart F Schlossman
CD3-negative natural killer cells express zeta TCR as part of a novel molecular complex.
Nature 1989;341(6238):159-62.
1989: M A Caligiuri; C Murray; H Levine; J A Longtine; Jerome Ritz
Clonal evidence for the induction of NKH1 on activated human thymocytes. Functional changes associated with antigen expression.
European journal of immunology 1989;19(9):1735-9.
1989: Jerome Ritz
The role of natural killer cells in immune surveillance.
The New England journal of medicine 1989;320(26):1748-9.
1989: C F Scott; S Bolender; G D McIntyre; J Holldack; J M Lambert; Yeldur Venkatesh; Chikao Morimoto; Jerome Ritz; Stuart F Schlossman
Activation of human cytolytic cells through CD2/T11. Comparison of the requirements for the induction and direction of lysis of tumor targets by T cells and NK cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(11):4105-12.
1989: L D Bosserman; C Murray; Tak Takvorian; Kenneth C Anderson; Arnold S Freedman; J Fitzsimmons; F Coral; Lee M Nadler; Stuart F Schlossman; Jerome Ritz
Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients.
Bone marrow transplantation 1989;4(3):239-45.
1989: M M Kamada; J Michon; Jerome Ritz; J Holldack; W E Serafin; K Frank Austen; R P MacDermott; Richard L Stevens
Identification of carboxypeptidase and tryptic esterase activities that are complexed to proteoglycans in the secretory granules of human cloned natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(2):609-15.
1989: Kenneth C Anderson; B A Barut; Jerome Ritz; Arnold S Freedman; Lee M Nadler
Autologous bone marrow transplantation therapy for multiple myeloma.
European journal of haematology. Supplementum 1989;51():157-63.
1988: T J Ernst; A Gazdar; Jerome Ritz; Margaret A Shipp
Identification of a second transforming gene, rasn, in a human multiple myeloma line with a rearranged c-myc allele.
Blood 1988;72(4):1163-7.
1988: Margaret A Shipp; N E Richardson; P H Sayre; N R Brown; E L Masteller; Linda K Clayton; Jerome Ritz; Ellis L Reinherz
Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(13):4819-23.
1988: David A Hafler; Jerome Ritz; S F Schlossman; Howard L Weiner
Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses.
Journal of immunology (Baltimore, Md. : 1950) 1988;141(1):131-8.
1988: J M Michon; M A Caligiuri; S M Hazanow; H Levine; Stuart F Schlossman; Jerome Ritz
Induction of natural killer effectors from human thymus with recombinant IL-2.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(10):3660-7.
1988: R E Schmidt; J P Caulfield; J Michon; A Hein; M M Kamada; R P MacDermott; R L Stevens; Jerome Ritz
T11/CD2 activation of cloned human natural killer cells results in increased conjugate formation and exocytosis of cytolytic granules.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(3):991-1002.
1988: Jerome Ritz; R E Schmidt; J Michon; T Hercend; S F Schlossman
Characterization of functional surface structures on human natural killer cells.
Advances in immunology 1988;42():181-211.
1988: Arnold S Freedman; T Takvorian; Lee M Nadler; Kenneth C Anderson; Stephen E Sallan; Jerome Ritz
Autologous bone marrow transplantation in acute leukemia and lymphoma following ex vivo treatment with monoclonal antibodies and complement.
Cancer treatment and research 1988;38():265-83.
1987: M Caligiuri; C Murray; Dedra Buchwald; H Levine; P Cheney; D Peterson; A L Komaroff; Jerome Ritz
Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(10):3306-13.
1987: Frederick P Li; K Gimbrere; Jerome Ritz; H Saito; J A Longtine
Lymphoma with clonal T-cell receptor gene rearrangement in a 25-year survivor of Hodgkin's disease.
Cancer 1987;60(9):2213-8.
1987: Tak Takvorian; George P Canellos; Jerome Ritz; Arnold S Freedman; Kenneth C Anderson; Peter M Mauch; Nancy J Tarbell; F Coral; H Daley; B Yeap
Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis.
The New England journal of medicine 1987;316(24):1499-505.
1987: P Hokland; M Hokland; J Daley; Jerome Ritz
Identification and cloning of a prethymic precursor T lymphocyte from a population of common acute lymphoblastic leukemia antigen (CALLA)-positive fetal bone marrow cells.
The Journal of experimental medicine 1987;165(6):1749-54.
1987: J P Caulfield; A Hein; R E Schmidt; Jerome Ritz
Ultrastructural evidence that the granules of human natural killer cell clones store membrane in a nonbilayer phase.
The American journal of pathology 1987;127(2):305-16.
1987: H M Rosenblatt; D E Lewis; J Sklar; M L Cleary; N Parikh; N Galili; Jerome Ritz; W T Shearer
Epstein-Barr virus-transformed B-cell line (DV-1) derived from bone marrow of a patient with severe combined immunodeficiency and immunoblastic lymphoma.
Pediatric research 1987;21(4):331-7.
1987: Kenneth C Anderson; Jerome Ritz; Tak Takvorian; F Coral; H Daley; B C Gorgone; Arnold S Freedman; George P Canellos; Stuart F Schlossman; Lee M Nadler
Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrow.
Blood 1987;69(2):597-604.
1987: Kenneth C Anderson; Lee M Nadler; T Takvorian; Arnold S Freedman; George P Canellos; S F Schlossman; Jerome Ritz
Monoclonal antibodies: their use in bone marrow transplantation.
Progress in hematology 1987;15():137-81.
1987: R E Schmidt; J M Michon; J Woronicz; S F Schlossman; Ellis L Reinherz; Jerome Ritz
Enhancement of natural killer function through activation of the T11 E rosette receptor.
The Journal of clinical investigation 1987;79(1):305-8.
1987: F Herrmann; R E Schmidt; Jerome Ritz; James D Griffin
In vitro regulation of human hematopoiesis by natural killer cells: analysis at a clonal level.
Blood 1987;69(1):246-54.
1987: C M Niemeyer; Jerome Ritz; K Donahue; Stephen E Sallan
Monoclonal-antibody-purged autologous bone marrow transplantation for relapsed non-T-cell acute lymphoblastic leukemia in childhood.
Haematology and blood transfusion 1987;31():67-74.
1987: Reinhold E Schmidt; S F Schlossman; Ellis L Reinherz; Jerome Ritz
Activation of natural killer function through the T11/E rosette receptor.
Haematology and blood transfusion 1987;31():347-50.
1986: T F Tedder; R E Schmidt; C E Rudd; M M Kornacki; Jerome Ritz; S F Schlossman
Function of the LFA-1 and T4 molecules in the direct activation of resting human B lymphocytes by T lymphocytes.
European journal of immunology 1986;16(12):1539-43.
1986: L Delmon; A Ythier; P Moingeon; A Nowill; C Bayle; J L Pico; M Hayat; Jerome Ritz; T Hercend
Characterization of antileukemia cells' cytotoxic effector function. Implications for monitoring natural killer responses following allogeneic bone marrow transplantation.
Transplantation 1986;42(3):252-6.
1986: Norman L Letvin; Laura V Chalifoux; Keith A Reimann; Jerome Ritz; S F Schlossman; J M Lambert
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. Delivery of ribosome-inactivating proteins to spleen and lymph node T cells.
The Journal of clinical investigation 1986;78(3):666-73.
1986: R G Knowlton; V A Brown; Jeffrey Carl Braman; David Barker; J W Schumm; C Murray; T Takvorian; Jerome Ritz; H Donis-Keller
Use of highly polymorphic DNA probes for genotypic analysis following bone marrow transplantation.
Blood 1986;68(2):378-85.
1986: A Rohatiner; R Gelber; S F Schlossman; Jerome Ritz
Depletion of T cells from human bone marrow using monoclonal antibodies and rabbit complement. A quantitative and functional analysis.
Transplantation 1986;42(1):73-80.
1986: R E Schmidt; C Murray; J F Daley; S F Schlossman; Jerome Ritz
A subset of natural killer cells in peripheral blood displays a mature T cell phenotype.
The Journal of experimental medicine 1986;164(1):351-6.
1986: C Milanese; Robert Siliciano; R E Schmidt; Jerome Ritz; N E Richardson; Ellis L Reinherz
A lymphokine that activates the cytolytic program of both cytotoxic T lymphocyte and natural killer clones.
The Journal of experimental medicine 1986;163(6):1583-8.
1986: R E Schmidt; G T Bartley; S S Lee; J F Daley; hans-dieter royer; H Levine; Ellis L Reinherz; S F Schlossman; Jerome Ritz
Expression of the NKTa clonotype in a series of human natural killer clones with identical cytotoxic specificity.
The Journal of experimental medicine 1986;163(4):812-25.
1986: M Bregni; P De Fabritiis; V Raso; Joel S Greenberger; Jeffrey Lipton; Lee M Nadler; L Rothstein; Jerome Ritz; R C Bast
Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates.
Cancer research 1986;46(3):1208-13.
1986: N L Letvin; V S Goldmacher; Jerome Ritz; J M Yetz; S F Schlossman; J M Lambert
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates.
The Journal of clinical investigation 1986;77(3):977-84.
1986: T Hercend; T Takvorian; A Nowill; R Tantravahi; P Moingeon; Kenneth C Anderson; C Murray; C Bohuon; A Ythier; Jerome Ritz
Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation.
Blood 1986;67(3):722-8.
1986: P De Fabritiis; M Bregni; Jeffrey Lipton; C Reynolds; Lee M Nadler; Jerome Ritz; R C Bast
Antigenic heterogeneity among Burkitt's lymphoma cells surviving treatment with monoclonal antibody and complement.
Leukemia research 1986;10(1):35-42.
1986: Victor S Goldmacher; J M Lambert; A Y Young; J Anderson; N L Tinnel; M Kornacki; Jerome Ritz; W A Blättler
Expression of the common acute lymphoblastic leukemia antigen (CALLA) on the surface of individual cells of human lymphoblastoid lines.
Journal of immunology (Baltimore, Md. : 1950) 1986;136(1):320-5.
1985: R E Schmidt; T Hercend; S F Schlossman; Jerome Ritz
Functional surface structures on human natural killer cells.
Klinische Wochenschrift 1985;63(23):1189-200.
1985: R P MacDermott; R E Schmidt; J P Caulfield; A Hein; G T Bartley; Jerome Ritz; S F Schlossman; K F Austen; R L Stevens
Proteoglycans in cell-mediated cytotoxicity. Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis.
The Journal of experimental medicine 1985;162(6):1771-87.
1985: R E Schmidt; R P MacDermott; G Bartley; M Bertovich; D A Amato; K F Austen; S F Schlossman; R L Stevens; Jerome Ritz
Specific release of proteoglycans from human natural killer cells during target lysis.
Nature 1985;318(6043):289-91.
1985: Robert Siliciano; J C Pratt; R E Schmidt; Jerome Ritz; Ellis L Reinherz
Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein.
Nature 1985;317(6036):428-30.
1985: N L Letvin; Jerome Ritz; L J Guida; J M Yetz; J M Lambert; Ellis L Reinherz; S F Schlossman
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates: I. Effects of anti-T11 antibodies on the circulating T cell pool.
Blood 1985;66(4):961-6.
1985: P Hokland; Jerome Ritz; S F Schlossman; Lee M Nadler
Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(3):1746-51.
1985: M Takahashi; Jerome Ritz; G M Cooper
Activation of a novel human transforming gene, ret, by DNA rearrangement.
Cell 1985;42(2):581-8.
1985: R E Schmidt; G Bartley; H Levine; S F Schlossman; Jerome Ritz
Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(2):1020-5.
1985: R E Schmidt; T Hercend; David A Fox; Armand Bensussan; G Bartley; J F Daley; S F Schlossman; Ellis L Reinherz; Jerome Ritz
The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(1):672-8.
1985: Jerome Ritz; T J Campen; R E Schmidt; hans-dieter royer; T Hercend; R E Hussey; Ellis L Reinherz
Analysis of T-cell receptor gene rearrangement and expression in human natural killer clones.
Science (New York, N.Y.) 1985;228(4707):1540-3.
1985: William T Shearer; Jerome Ritz; M J Finegold; I C Guerra; Howard M Rosenblatt; D E Lewis; M S Pollack; L H Taber; C V Sumaya; Carl Grumet
Epstein-Barr virus-associated B-cell proliferations of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency.
The New England journal of medicine 1985;312(18):1151-9.
1985: P De Fabritiis; M Bregni; Jeffrey Lipton; Joel S Greenberger; Lee M Nadler; L Rothstein; M Korbling; Jerome Ritz; R C Bast
Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement.
Blood 1985;65(5):1064-70.
1985: T Hercend; James D Griffin; Armand Bensussan; R E Schmidt; M A Edson; A Brennan; C Murray; J F Daley; S F Schlossman; Jerome Ritz
Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.
The Journal of clinical investigation 1985;75(3):932-43.
1985: Joel S Greenberger; L Rothstein; P DeFabritiis; M Bregni; R Bast; Jerome Ritz; Lee M Nadler; Jeffrey Lipton; M A Sakakeeny
Effects of monoclonal antibody and complement treatment of human marrow on hematopoiesis in continuous bone marrow culture.
Cancer research 1985;45(2):758-67.
1985: R C Bast; P De Fabritiis; Jeffrey Lipton; R Gelber; C Maver; Lee M Nadler; Stephen E Sallan; Jerome Ritz
Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement.
Cancer research 1985;45(2):499-503.
1984: T Hercend; R Schmidt; A Brennan; M A Edson; Ellis L Reinherz; S F Schlossman; Jerome Ritz
Identification of a 140-kDa activation antigen as a target structure for a series of human cloned natural killer cell lines.
European journal of immunology 1984;14(9):844-52.
1984: P Hokland; Lee M Nadler; James D Griffin; S F Schlossman; Jerome Ritz
Purification of common acute lymphoblastic leukemia antigen positive cells from normal human bone marrow.
Blood 1984;64(3):662-6.
1984: T Hercend; S Meuer; A Brennan; M A Edson; Oreste Acuto; Ellis L Reinherz; S F Schlossman; Jerome Ritz
Natural killer-like function of activated T lymphocytes: differential blocking effects of monoclonal antibodies specific for a 90-kDa clonotypic structure.
Cellular immunology 1984;86(2):381-92.
1984: Jerome Ritz; R C Bast; T Takvorian; Stephen E Sallan
Clinical applications of monoclonal antibodies in acute leukemia.
Annals of the New York Academy of Sciences 1984;428():308-17.
1983: T Hercend; S Meuer; A Brennan; M A Edson; Oreste Acuto; Ellis L Reinherz; S F Schlossman; Jerome Ritz
Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function.
The Journal of experimental medicine 1983;158(5):1547-60.
1983: Jerome Ritz
Use of monoclonal antibodies in autologous and allogeneic bone marrow transplantation.
Clinics in haematology 1983;12(3):813-32.
1983: Alan M Diamond; G M Cooper; Jerome Ritz; M A Lane
Identification and molecular cloning of the human Blym transforming gene activated in Burkitt's lymphomas.
Nature 1983;305(5930):112-6.
1983: James D Griffin; Jerome Ritz; R P Beveridge; Jeffrey Lipton; J F Daley; S F Schlossman
Expression of MY7 antigen on myeloid precursor cells.
International journal of cell cloning 1983;1(1):33-48.
1983: M F Greaves; G Hariri; R A Newman; D R Sutherland; M A Ritter; Jerome Ritz
Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts.
Blood 1983;61(4):628-39.
1983: L Pegoraro; L Matera; Jerome Ritz; A Levis; A Palumbo; G Biagini
Establishment of a Ph1-positive human cell line (BV173).
Journal of the National Cancer Institute 1983;70(3):447-53.
1983: R C Bast; Jerome Ritz; Jeffrey Lipton; M Feeney; Stephen E Sallan; D G Nathan; S F Schlossman
Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
Cancer research 1983;43(3):1389-94.
1983: T Hercend; Ellis L Reinherz; S Meuer; S F Schlossman; Jerome Ritz
Phenotypic and functional heterogeneity of human cloned natural killer cell lines.
Nature 1983;301(5896):158-60.
1983: M Hokland; Jerome Ritz; P Hokland
Interferon-induced changes in expression of antigens defined by monoclonal antibodies on malignant and nonmalignant mononuclear hematopoietic cells.
Journal of interferon research 1983;3(2):199-210.
1983: P Hokland; P Rosenthal; James D Griffin; Lee M Nadler; J Daley; M Hokland; S F Schlossman; Jerome Ritz
Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA).
The Journal of experimental medicine 1983;157(1):114-29.
1983: James D Griffin; R F Todd; Jerome Ritz; Lee M Nadler; George P Canellos; D Rosenthal; M Gallivan; R P Beveridge; H Weinstein; D Karp; S F Schlossman
Differentiation patterns in the blastic phase of chronic myeloid leukemia.
Blood 1983;61(1):85-91.
1983: Jerome Ritz; Stephen E Sallan; R C Bast; Jeffrey Lipton; D G Nathan; S F Schlossman
In vitro treatment with monoclonal antibody prior to autologous bone marrow transplantation in acute lymphoblastic leukemia.
Haematology and blood transfusion 1983;28():117-23.
1982: T Hercend; S Meuer; Ellis L Reinherz; S F Schlossman; Jerome Ritz
Generation of a cloned NK cell line derived from the "null cell" fraction of human peripheral blood.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(3):1299-305.
1982: Lee M Nadler; Jerome Ritz; M P Bates; E K Park; Kenneth C Anderson; Stephen E Sallan; S F Schlossman
Induction of human B cell antigens in non-T cell acute lymphoblastic leukemia.
The Journal of clinical investigation 1982;70(2):433-42.
1982: Jerome Ritz; Stephen E Sallan; R C Bast; Jeffrey Lipton; L A Clavell; M Feeney; T Hercend; D G Nathan; S F Schlossman
Autologous bone-marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in-vitro treatment with J5 monoclonal antibody and complement.
Lancet 1982;2(8289):60-3.
1982: J M Rosenberg; H L Kirschenbaum; G Saleem; Jerome Ritz; F P Martino
Benoxaprofen and cyproheptadine.
The Journal of the Medical Society of New Jersey 1982;79(5):413-4.
1982: V Raso; Jerome Ritz; M Basala; S F Schlossman
Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Cancer research 1982;42(2):457-64.
1982: Jerome Ritz; S F Schlossman
Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma.
Blood 1982;59(1):1-11.
1981: Jerome Ritz; J M Pesando; J Notis-McConarty; L A Clavell; Stephen E Sallan; S F Schlossman
Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia.
Cancer research 1981;41(11 Pt 2):4771-5.
1981: T Hercend; Jerome Ritz; S F Schlossman; Ellis L Reinherz
Comparative expression of T9, T10, and Ia antigens on activated human T cell subsets.
Human immunology 1981;3(3):247-59.
1981: James D Griffin; Jerome Ritz; Lee M Nadler; S F Schlossman
Expression of myeloid differentiation antigens on normal and malignant myeloid cells.
The Journal of clinical investigation 1981;68(4):932-41.
1981: T Hercend; Lee M Nadler; J M Pesando; Ellis L Reinherz; S F Schlossman; Jerome Ritz
Expression of a 26,000-dalton glycoprotein on activated human T cells.
Cellular immunology 1981;64(1):192-9.
1981: Jerome Ritz; Lee M Nadler; A K Bhan; J Notis-McConarty; J M Pesando; S F Schlossman
Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage.
Blood 1981;58(3):648-52.
1981: J M Pesando; Lee M Nadler; H Lazarus; K J Tomaselli; P Stashenko; Jerome Ritz; H Levine; E J Yunis; S F Schlossman
Human cell lines express multiple populations of Ia-like molecules.
Human immunology 1981;3(1):67-76.
1981: L A Clavell; Jeffrey Lipton; R C Bast; M Kudisch; J Pesando; S F Scholssman; Jerome Ritz
Absence of common ALL antigen on normal bipotent myeloid, erythroid, and granulocyte progenitors.
Blood 1981;58(2):333-6.
1981: Jerome Ritz; J M Pesando; Stephen E Sallan; L A Clavell; J Notis-McConarty; P Rosenthal; S F Schlossman
Serotherapy of acute lymphoblastic leukemia with monoclonal antibody.
Blood 1981;58(1):141-52.
1981: Alain Bernard; Laurence Boumsell; Ellis L Reinherz; Lee M Nadler; Jerome Ritz; helene coppin; Y Richard; F Valensi; Jean Dausset; G Flandrin; J Lemerle; S F Schlossman
Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma.
Blood 1981;57(6):1105-10.
1981: Laurence Boumsell; Alain Bernard; Ellis L Reinherz; Lee M Nadler; Jerome Ritz; helene coppin; Y Richard; L Dubertret; F Valensi; L Degos; J Lemerle; G Flandrin; Jean Dausset; S F Schlossman
Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cells.
Blood 1981;57(3):526-30.
1981: J M Pesando; Jerome Ritz; H Lazarus; K J Tomaselli; S F Schlossman
Fate of a common acute lymphoblastic leukemia antigen during modulation by monoclonal antibody.
Journal of immunology (Baltimore, Md. : 1950) 1981;126(2):540-4.
1981: Lee M Nadler; Jerome Ritz; James D Griffin; R F Todd; Ellis L Reinherz; S F Schlossman
Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies.
Progress in hematology 1981;12():187-225.
1981: Lee M Nadler; Jerome Ritz; R Hardy; J M Pesando; S F Schlossman; P Stashenko
A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
The Journal of clinical investigation 1981;67(1):134-40.
1981: R F Todd; James D Griffin; Jerome Ritz; Lee M Nadler; T Abrams; S F Schlossman
Expression of normal monocyte-macrophage differentiation antigens on HL60 promyelocytes undergoing differentiation induced by leukocyte-conditioned medium or phorbol diester.
Leukemia research 1981;5(6):491-5.
1981: M F Greaves; J B Robinson; D Delia; Jerome Ritz; S Schlossman; C Sieff; G Goldstein; P Kung; F J Bollum; P A Edwards
Comparative antigenic phenotypes of normal and leukemic hemopoietic precursor cells analysed with a "library" of monoclonal antibodies.
Haematology and blood transfusion 1981;26():296-304.
1980: Jerome Ritz; J M Pesando; J Notis-McConarty; S F Schlossman
Modulation of human acute lymphoblastic leukemia antigen induced by monoclonal antibody in vitro.
Journal of immunology (Baltimore, Md. : 1950) 1980;125(4):1506-14.
1980: J M Pesando; Jerome Ritz; H Levine; C Terhorst; H Lazarus; S F Schlossman
Human leukemia-associated antigen: relation to a family of surface glycoproteins.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(6):2794-9.
1980: Stephen E Sallan; Jerome Ritz; J Pesando; R Gelber; C O'Brien; S Hitchcock; F Coral; S F Schlossman
Cell surface antigens: prognostic implications in childhood acute lymphoblastic leukemia.
Blood 1980;55(3):395-402.
1980: Jerome Ritz; J M Pesando; J Notis-McConarty; H Lazarus; S F Schlossman
A monoclonal antibody to human acute lymphoblastic leukaemia antigen.
Nature 1980;283(5747):583-5.